Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1991; 84(Suppl 18): 10–17.
PMCID: PMC1293030

Pathogenesis and management of lung disease in cystic fibrosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Zach MS. Lung disease in cystic fibrosis--an updated concept. Pediatr Pulmonol. 1990;8(3):188–202. [PubMed]
  • Woods DE, Straus DC, Johanson WG, Jr, Berry VK, Bass JA. Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun. 1980 Sep;29(3):1146–1151. [PMC free article] [PubMed]
  • Ramphal R, Pyle M. Adherence of mucoid and nonmucoid Pseudomonas aeruginosa to acid-injured tracheal epithelium. Infect Immun. 1983 Jul;41(1):345–351. [PMC free article] [PubMed]
  • Ramphal R, Sadoff JC, Pyle M, Silipigni JD. Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium. Infect Immun. 1984 Apr;44(1):38–40. [PMC free article] [PubMed]
  • Ramphal R, Pier GB. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells. Infect Immun. 1985 Jan;47(1):1–4. [PMC free article] [PubMed]
  • Fick RB., Jr Pathogenesis of the pseudomonas lung lesion in cystic fibrosis. Chest. 1989 Jul;96(1):158–164. [PubMed]
  • Sanchis J, Dolovich M, Rossman C, Wilson W, Newhouse M. Pulmonary mucociliary clearance in cystic fibrosis. N Engl J Med. 1973 Mar 29;288(13):651–654. [PubMed]
  • Yeates DB, Sturgess JM, Kahn SR, Levison H, Aspin N. Mucociliary transport in trachea of patients with cystic fibrosis. Arch Dis Child. 1976 Jan;51(1):28–33. [PMC free article] [PubMed]
  • Hornick DB. Pulmonary host defense: defects that lead to chronic inflammation of the airway. Clin Chest Med. 1988 Dec;9(4):669–678. [PubMed]
  • Ramphal R, Small PM, Shands JW, Jr, Fischlschweiger W, Small PA., Jr Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation. Infect Immun. 1980 Feb;27(2):614–619. [PMC free article] [PubMed]
  • Mearns MB, Hunt GH, Rushworth R. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child. 1972 Dec;47(256):902–907. [PMC free article] [PubMed]
  • Kuusela P. Fibronectin binds to Staphylococcus aureus. Nature. 1978 Dec 14;276(5689):718–720. [PubMed]
  • Woods DE, Bass JA, Johanson WG, Jr, Straus DC. Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun. 1980 Dec;30(3):694–699. [PMC free article] [PubMed]
  • Russell NJ, Gacesa P. Chemistry and biology of the alginate of mucoid strains of Pseudomonas aeruginosa in cystic fibrosis. Mol Aspects Med. 1988;10(1):1–91. [PubMed]
  • Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun. 1980 May;28(2):546–556. [PMC free article] [PubMed]
  • Baltimore RS, Mitchell M. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains. J Infect Dis. 1980 Feb;141(2):238–247. [PubMed]
  • Hingley ST, Hastie AT, Kueppers F, Higgins ML, Weinbaum G, Shryock T. Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia. Infect Immun. 1986 Jan;51(1):254–262. [PMC free article] [PubMed]
  • Høiby N, Döring G, Schiøtz PO. The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol. 1986;40:29–53. [PubMed]
  • Schiøtz PO, Clemmensen I, Høiby N. Immunoglobulins and albumin in sputum from patients with cystic fibrosis. A study of protein stability and presence of proteases. Acta Pathol Microbiol Scand C. 1980 Oct;88(5):275–280. [PubMed]
  • Goldstein W, Döring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis. 1986 Jul;134(1):49–56. [PubMed]
  • Suter S, Schaad UB, Roux L, Nydegger UE, Waldvogel FA. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis. 1984 Apr;149(4):523–531. [PubMed]
  • Suter S. Imbalance between polymorphonuclear leukocyte proteases and antiproteases in chronic pyogenic infections and its relation to the proteolysis of complement component C3. Complement. 1986;3(1):1–24. [PubMed]
  • Bruce MC, Poncz L, Klinger JD, Stern RC, Tomashefski JF, Jr, Dearborn DG. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis. 1985 Sep;132(3):529–535. [PubMed]
  • Solomon A, Gramse M, Havemann K. Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes. Eur J Immunol. 1978 Nov;8(11):782–785. [PubMed]
  • Prince HE, Folds JD, Spitznagel JK. Proteolysis of human IgG by human polymorphonuclear leucocyte elastase produces an Fc fragment with in vitro biological activity. Clin Exp Immunol. 1979 Jul;37(1):162–168. [PubMed]
  • Esterly JR, Oppenheimer EH. Observations in cystic fibrosis of the pancreas. 3. Pulmonary lesions. Johns Hopkins Med J. 1968 Feb;122(2):94–101. [PubMed]
  • Wentworth P, Gough J, Wentworth JE. Pulmonary changes and cor pulmonale in mucoviscidosis. Thorax. 1968 Nov;23(6):582–589. [PMC free article] [PubMed]
  • Bedrossian CW, Greenberg SD, Singer DB, Hansen JJ, Rosenberg HS. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol. 1976 Mar;7(2):195–204. [PubMed]
  • Tomashefski JF, Jr, Bruce M, Goldberg HI, Dearborn DG. Regional distribution of macroscopic lung disease in cystic fibrosis. Am Rev Respir Dis. 1986 Apr;133(4):535–540. [PubMed]
  • Sobonya RE, Taussig LM. Quantitative aspects of lung pathology in cystic fibrosis. Am Rev Respir Dis. 1986 Aug;134(2):290–295. [PubMed]
  • Chrispin AR, Norman AP. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol. 1974;2(2):101–105. [PubMed]
  • Mellins RB, Levin OR, Ingram RH, Jr, Fishman AP. Obstructive disease of the airways in cystic fibrosis. Pediatrics. 1968 Mar;41(3):560–573. [PubMed]
  • Zapletal A, Motoyama EK, Gibson LE, Bouhuys A. Pulmonary mechanics in asthma and cystic fibrosis. Pediatrics. 1971 Jul;48(1):64–72. [PubMed]
  • Landau LI, Phelan PD. The spectrum of cystic fibrosis. A study of pulmonary mechanics in 46 patients. Am Rev Respir Dis. 1973 Sep;108(3):593–602. [PubMed]
  • Zapletal A, Houstek J, Samanek M, Vavrova V, Srajer J. Lung function abnormalities in cystic fibrosis and changes during growth. Bull Eur Physiopathol Respir. 1979 Jul-Aug;15(4):575–592. [PubMed]
  • Ormerod LP, Thomson RA, Anderson CM, Stableforth DE. Reversible airway obstruction in cystic fibrosis. Thorax. 1980 Oct;35(10):768–772. [PMC free article] [PubMed]
  • Hordvik NL, König P, Morris D, Kreutz C, Barbero GJ. A longitudinal study of bronchodilator responsiveness in cystic fibrosis. Am Rev Respir Dis. 1985 Jun;131(6):889–893. [PubMed]
  • Jones JG, Fraser RB, Nadel JA. Effect of changing airway mechanics on maximum expiratory flow. J Appl Physiol. 1975 Jun;38(6):1012–1021. [PubMed]
  • Zach MS, Oberwaldner B, Forche G, Polgar G. Bronchodilators increase airway instability in cystic fibrosis. Am Rev Respir Dis. 1985 Apr;131(4):537–543. [PubMed]
  • Nicolai T, Hüttner K, Zach M. Der Einfluss von Luftwegsinstabilität und Alveolargaskompression auf bronchodilatatorinduzierte Anderungen von Fluss-Volumenkurve und Luftwegsresistance. Prax Klin Pneumol. 1988 Feb;42(2):45–49. [PubMed]
  • Eber E, Oberwaldner B, Zach MS. Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. Pediatr Pulmonol. 1988;4(4):205–212. [PubMed]
  • Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med. 1981 Dec 17;305(25):1489–1495. [PubMed]
  • App EM, King M, Helfesrieder R, Köhler D, Matthys H. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am Rev Respir Dis. 1990 Mar;141(3):605–612. [PubMed]
  • Van Wye JE, Collins MS, Baylor M, Pennington JE, Hsu YP, Sampanvejsopa V, Moss RB. Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol. 1990;9(1):7–18. [PubMed]
  • Langford DT, Hiller J. Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results. Arch Dis Child. 1984 Dec;59(12):1131–1134. [PMC free article] [PubMed]
  • Michel BC. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987. Chest. 1988 Aug;94(2 Suppl):129S–140S. [PubMed]
  • Gold R, Carpenter S, Heurter H, Corey M, Levison H. Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr. 1987 Dec;111(6 Pt 1):907–913. [PubMed]
  • Regelmann WE, Elliott GR, Warwick WJ, Clawson CC. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):914–921. [PubMed]
  • Zach MS, Oberwaldner B. Chest physiotherapy--the mechanical approach to antiinfective therapy in cystic fibrosis. Infection. 1987;15(5):381–384. [PubMed]
  • Oberwaldner B, Evans JC, Zach MS. Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatr Pulmonol. 1986 Nov-Dec;2(6):358–367. [PubMed]
  • Reisman JJ, Rivington-Law B, Corey M, Marcotte J, Wannamaker E, Harcourt D, Levison H. Role of conventional physiotherapy in cystic fibrosis. J Pediatr. 1988 Oct;113(4):632–636. [PubMed]
  • Auerbach HS, Williams M, Kirkpatrick JA, Colten HR. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet. 1985 Sep 28;2(8457):686–688. [PubMed]
  • Suter S, Schaad UB, Tegner H, Ohlsson K, Desgrandchamps D, Waldvogel FA. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis. 1986 May;153(5):902–909. [PubMed]
  • Mansell AL, Andersen JC, Muttart CR, Ores CN, Loeff DS, Levy JS, Heird WC. Short-term pulmonary effects of total parenteral nutrition in children with cystic fibrosis. J Pediatr. 1984 May;104(5):700–705. [PubMed]
  • Levy LD, Durie PR, Pencharz PB, Corey ML. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr. 1985 Aug;107(2):225–230. [PubMed]
  • Shepherd R, Cooksley WG, Cooke WD. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis. J Pediatr. 1980 Sep;97(3):351–357. [PubMed]
  • Olsen CR, Stevens AE, McIlroy MB. Rigidity of tracheae and bronchi during muscular constriction. J Appl Physiol. 1967 Jul;23(1):27–34. [PubMed]
  • Scott J, Higenbottam T, Hutter J, Hodson M, Stewart S, Penketh A, Wallwork J. Heart-lung transplantation for cystic fibrosis. Lancet. 1988 Jul 23;2(8604):192–194. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press